nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP3A4—Thiotepa—sarcoma	0.149	0.191	CbGbCtD
Fesoterodine—ABCB1—Dactinomycin—sarcoma	0.12	0.153	CbGbCtD
Fesoterodine—ABCB1—Mitoxantrone—sarcoma	0.107	0.137	CbGbCtD
Fesoterodine—ABCB1—Vincristine—sarcoma	0.0737	0.0941	CbGbCtD
Fesoterodine—ABCB1—Etoposide—sarcoma	0.0675	0.0862	CbGbCtD
Fesoterodine—CYP3A4—Mitoxantrone—sarcoma	0.0642	0.0819	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—sarcoma	0.0461	0.0588	CbGbCtD
Fesoterodine—CYP3A4—Vincristine—sarcoma	0.0442	0.0564	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—sarcoma	0.0434	0.0554	CbGbCtD
Fesoterodine—CYP3A4—Etoposide—sarcoma	0.0405	0.0517	CbGbCtD
Fesoterodine—CYP3A4—Doxorubicin—sarcoma	0.0276	0.0352	CbGbCtD
Fesoterodine—Gamma-glutamyltransferase increased—Thiotepa—sarcoma	0.00418	0.0193	CcSEcCtD
Fesoterodine—Gamma-glutamyltransferase increased—Mitoxantrone—sarcoma	0.00361	0.0167	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00314	0.0145	CcSEcCtD
Fesoterodine—Urinary retention—Thiotepa—sarcoma	0.00237	0.011	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Thiotepa—sarcoma	0.0022	0.0102	CcSEcCtD
Fesoterodine—Urinary retention—Vincristine—sarcoma	0.00211	0.00971	CcSEcCtD
Fesoterodine—Dysuria—Thiotepa—sarcoma	0.00202	0.00931	CcSEcCtD
Fesoterodine—Abdominal pain upper—Mitoxantrone—sarcoma	0.00197	0.00908	CcSEcCtD
Fesoterodine—Infestation NOS—Thiotepa—sarcoma	0.00192	0.00888	CcSEcCtD
Fesoterodine—Infestation—Thiotepa—sarcoma	0.00192	0.00888	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.0019	0.00877	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Thiotepa—sarcoma	0.00182	0.00839	CcSEcCtD
Fesoterodine—Dysuria—Vincristine—sarcoma	0.00179	0.00825	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00173	0.00799	CcSEcCtD
Fesoterodine—Urinary tract disorder—Thiotepa—sarcoma	0.00171	0.00787	CcSEcCtD
Fesoterodine—Urethral disorder—Thiotepa—sarcoma	0.00169	0.00781	CcSEcCtD
Fesoterodine—Urinary tract infection—Mitoxantrone—sarcoma	0.00162	0.00745	CcSEcCtD
Fesoterodine—Eye disorder—Thiotepa—sarcoma	0.00161	0.00745	CcSEcCtD
Fesoterodine—Cardiac disorder—Thiotepa—sarcoma	0.0016	0.0074	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Etoposide—sarcoma	0.00158	0.0073	CcSEcCtD
Fesoterodine—Mediastinal disorder—Thiotepa—sarcoma	0.00156	0.00718	CcSEcCtD
Fesoterodine—Mental disorder—Thiotepa—sarcoma	0.00151	0.00698	CcSEcCtD
Fesoterodine—Urinary tract disorder—Vincristine—sarcoma	0.00151	0.00698	CcSEcCtD
Fesoterodine—Urethral disorder—Vincristine—sarcoma	0.0015	0.00693	CcSEcCtD
Fesoterodine—Back pain—Thiotepa—sarcoma	0.00145	0.00671	CcSEcCtD
Fesoterodine—Cardiac disorder—Vincristine—sarcoma	0.00142	0.00656	CcSEcCtD
Fesoterodine—Vision blurred—Thiotepa—sarcoma	0.00142	0.00654	CcSEcCtD
Fesoterodine—Infestation NOS—Etoposide—sarcoma	0.00138	0.00638	CcSEcCtD
Fesoterodine—Infestation—Etoposide—sarcoma	0.00138	0.00638	CcSEcCtD
Fesoterodine—Mediastinal disorder—Vincristine—sarcoma	0.00138	0.00637	CcSEcCtD
Fesoterodine—Mental disorder—Vincristine—sarcoma	0.00134	0.00619	CcSEcCtD
Fesoterodine—Cough—Thiotepa—sarcoma	0.00131	0.00605	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Etoposide—sarcoma	0.00131	0.00603	CcSEcCtD
Fesoterodine—Back pain—Vincristine—sarcoma	0.00129	0.00595	CcSEcCtD
Fesoterodine—Dry eye—Epirubicin—sarcoma	0.00128	0.0059	CcSEcCtD
Fesoterodine—Dysgeusia—Mitoxantrone—sarcoma	0.00127	0.00587	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00127	0.00586	CcSEcCtD
Fesoterodine—Back pain—Mitoxantrone—sarcoma	0.00126	0.00579	CcSEcCtD
Fesoterodine—Confusional state—Thiotepa—sarcoma	0.00124	0.00571	CcSEcCtD
Fesoterodine—Urinary tract disorder—Etoposide—sarcoma	0.00123	0.00565	CcSEcCtD
Fesoterodine—Vision blurred—Mitoxantrone—sarcoma	0.00122	0.00565	CcSEcCtD
Fesoterodine—Infection—Thiotepa—sarcoma	0.00122	0.00562	CcSEcCtD
Fesoterodine—Urethral disorder—Etoposide—sarcoma	0.00122	0.00561	CcSEcCtD
Fesoterodine—Infection—Dactinomycin—sarcoma	0.00121	0.00558	CcSEcCtD
Fesoterodine—Nervous system disorder—Thiotepa—sarcoma	0.0012	0.00555	CcSEcCtD
Fesoterodine—Vertigo—Vincristine—sarcoma	0.0012	0.00553	CcSEcCtD
Fesoterodine—Tachycardia—Thiotepa—sarcoma	0.0012	0.00553	CcSEcCtD
Fesoterodine—Skin disorder—Thiotepa—sarcoma	0.00119	0.0055	CcSEcCtD
Fesoterodine—Dry eye—Doxorubicin—sarcoma	0.00118	0.00546	CcSEcCtD
Fesoterodine—Eye disorder—Etoposide—sarcoma	0.00116	0.00535	CcSEcCtD
Fesoterodine—Cardiac disorder—Etoposide—sarcoma	0.00115	0.00531	CcSEcCtD
Fesoterodine—Cough—Mitoxantrone—sarcoma	0.00113	0.00523	CcSEcCtD
Fesoterodine—Mediastinal disorder—Etoposide—sarcoma	0.00112	0.00516	CcSEcCtD
Fesoterodine—Chest pain—Mitoxantrone—sarcoma	0.00111	0.0051	CcSEcCtD
Fesoterodine—Somnolence—Thiotepa—sarcoma	0.00109	0.00503	CcSEcCtD
Fesoterodine—Infection—Vincristine—sarcoma	0.00108	0.00499	CcSEcCtD
Fesoterodine—Dyspepsia—Thiotepa—sarcoma	0.00108	0.00498	CcSEcCtD
Fesoterodine—Confusional state—Mitoxantrone—sarcoma	0.00107	0.00493	CcSEcCtD
Fesoterodine—Nervous system disorder—Vincristine—sarcoma	0.00107	0.00492	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00106	0.00489	CcSEcCtD
Fesoterodine—Fatigue—Thiotepa—sarcoma	0.00106	0.00488	CcSEcCtD
Fesoterodine—Dysgeusia—Etoposide—sarcoma	0.00106	0.00488	CcSEcCtD
Fesoterodine—Infection—Mitoxantrone—sarcoma	0.00105	0.00486	CcSEcCtD
Fesoterodine—Fatigue—Dactinomycin—sarcoma	0.00105	0.00484	CcSEcCtD
Fesoterodine—Constipation—Thiotepa—sarcoma	0.00105	0.00484	CcSEcCtD
Fesoterodine—Back pain—Etoposide—sarcoma	0.00105	0.00482	CcSEcCtD
Fesoterodine—Tachycardia—Mitoxantrone—sarcoma	0.00103	0.00477	CcSEcCtD
Fesoterodine—Skin disorder—Mitoxantrone—sarcoma	0.00103	0.00475	CcSEcCtD
Fesoterodine—Feeling abnormal—Thiotepa—sarcoma	0.00101	0.00467	CcSEcCtD
Fesoterodine—Feeling abnormal—Dactinomycin—sarcoma	0.001	0.00463	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Thiotepa—sarcoma	0.001	0.00463	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000996	0.00459	CcSEcCtD
Fesoterodine—Insomnia—Vincristine—sarcoma	0.000985	0.00454	CcSEcCtD
Fesoterodine—Urticaria—Thiotepa—sarcoma	0.000975	0.0045	CcSEcCtD
Fesoterodine—Face oedema—Epirubicin—sarcoma	0.000971	0.00448	CcSEcCtD
Fesoterodine—Vertigo—Etoposide—sarcoma	0.000971	0.00448	CcSEcCtD
Fesoterodine—Abdominal pain—Thiotepa—sarcoma	0.00097	0.00448	CcSEcCtD
Fesoterodine—Abdominal pain—Dactinomycin—sarcoma	0.000963	0.00444	CcSEcCtD
Fesoterodine—Cough—Etoposide—sarcoma	0.000943	0.00435	CcSEcCtD
Fesoterodine—Somnolence—Mitoxantrone—sarcoma	0.000942	0.00435	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Vincristine—sarcoma	0.00094	0.00433	CcSEcCtD
Fesoterodine—Fatigue—Vincristine—sarcoma	0.000938	0.00433	CcSEcCtD
Fesoterodine—Dyspepsia—Mitoxantrone—sarcoma	0.000933	0.0043	CcSEcCtD
Fesoterodine—Constipation—Vincristine—sarcoma	0.000931	0.00429	CcSEcCtD
Fesoterodine—Dry skin—Epirubicin—sarcoma	0.000922	0.00425	CcSEcCtD
Fesoterodine—Chest pain—Etoposide—sarcoma	0.00092	0.00424	CcSEcCtD
Fesoterodine—Abdominal pain upper—Epirubicin—sarcoma	0.000919	0.00424	CcSEcCtD
Fesoterodine—Fatigue—Mitoxantrone—sarcoma	0.000914	0.00421	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000913	0.00421	CcSEcCtD
Fesoterodine—Constipation—Mitoxantrone—sarcoma	0.000907	0.00418	CcSEcCtD
Fesoterodine—Hypersensitivity—Thiotepa—sarcoma	0.000904	0.00417	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—sarcoma	0.000898	0.00414	CcSEcCtD
Fesoterodine—Hypersensitivity—Dactinomycin—sarcoma	0.000898	0.00414	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Vincristine—sarcoma	0.00089	0.0041	CcSEcCtD
Fesoterodine—Confusional state—Etoposide—sarcoma	0.000889	0.0041	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000887	0.00409	CcSEcCtD
Fesoterodine—Asthenia—Thiotepa—sarcoma	0.000881	0.00406	CcSEcCtD
Fesoterodine—Infection—Etoposide—sarcoma	0.000876	0.00404	CcSEcCtD
Fesoterodine—Asthenia—Dactinomycin—sarcoma	0.000874	0.00403	CcSEcCtD
Fesoterodine—Feeling abnormal—Mitoxantrone—sarcoma	0.000874	0.00403	CcSEcCtD
Fesoterodine—Pruritus—Thiotepa—sarcoma	0.000868	0.00401	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000867	0.004	CcSEcCtD
Fesoterodine—Tachycardia—Etoposide—sarcoma	0.000861	0.00397	CcSEcCtD
Fesoterodine—Abdominal pain—Vincristine—sarcoma	0.00086	0.00397	CcSEcCtD
Fesoterodine—Skin disorder—Etoposide—sarcoma	0.000856	0.00395	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—sarcoma	0.000853	0.00393	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—sarcoma	0.00085	0.00392	CcSEcCtD
Fesoterodine—Angina pectoris—Epirubicin—sarcoma	0.000847	0.0039	CcSEcCtD
Fesoterodine—Urticaria—Mitoxantrone—sarcoma	0.000842	0.00388	CcSEcCtD
Fesoterodine—Diarrhoea—Thiotepa—sarcoma	0.00084	0.00387	CcSEcCtD
Fesoterodine—Abdominal pain—Mitoxantrone—sarcoma	0.000838	0.00386	CcSEcCtD
Fesoterodine—Diarrhoea—Dactinomycin—sarcoma	0.000834	0.00384	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000821	0.00378	CcSEcCtD
Fesoterodine—Dysuria—Epirubicin—sarcoma	0.000813	0.00375	CcSEcCtD
Fesoterodine—Dizziness—Thiotepa—sarcoma	0.000812	0.00374	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000808	0.00373	CcSEcCtD
Fesoterodine—Hypersensitivity—Vincristine—sarcoma	0.000802	0.0037	CcSEcCtD
Fesoterodine—Somnolence—Etoposide—sarcoma	0.000784	0.00362	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—sarcoma	0.000783	0.00361	CcSEcCtD
Fesoterodine—Hypersensitivity—Mitoxantrone—sarcoma	0.000781	0.0036	CcSEcCtD
Fesoterodine—Asthenia—Vincristine—sarcoma	0.000781	0.0036	CcSEcCtD
Fesoterodine—Infestation NOS—Epirubicin—sarcoma	0.000775	0.00357	CcSEcCtD
Fesoterodine—Infestation—Epirubicin—sarcoma	0.000775	0.00357	CcSEcCtD
Fesoterodine—Rash—Thiotepa—sarcoma	0.000774	0.00357	CcSEcCtD
Fesoterodine—Dermatitis—Thiotepa—sarcoma	0.000773	0.00357	CcSEcCtD
Fesoterodine—Headache—Thiotepa—sarcoma	0.000769	0.00355	CcSEcCtD
Fesoterodine—Rash—Dactinomycin—sarcoma	0.000768	0.00354	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Etoposide—sarcoma	0.000761	0.00351	CcSEcCtD
Fesoterodine—Asthenia—Mitoxantrone—sarcoma	0.000761	0.00351	CcSEcCtD
Fesoterodine—Fatigue—Etoposide—sarcoma	0.00076	0.00351	CcSEcCtD
Fesoterodine—Constipation—Etoposide—sarcoma	0.000754	0.00348	CcSEcCtD
Fesoterodine—Urinary tract infection—Epirubicin—sarcoma	0.000753	0.00347	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—sarcoma	0.000752	0.00347	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000747	0.00345	CcSEcCtD
Fesoterodine—Diarrhoea—Vincristine—sarcoma	0.000745	0.00343	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Epirubicin—sarcoma	0.000733	0.00338	CcSEcCtD
Fesoterodine—Nausea—Thiotepa—sarcoma	0.000729	0.00336	CcSEcCtD
Fesoterodine—Feeling abnormal—Etoposide—sarcoma	0.000727	0.00335	CcSEcCtD
Fesoterodine—Diarrhoea—Mitoxantrone—sarcoma	0.000725	0.00335	CcSEcCtD
Fesoterodine—Nausea—Dactinomycin—sarcoma	0.000724	0.00334	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Etoposide—sarcoma	0.000721	0.00333	CcSEcCtD
Fesoterodine—Dizziness—Vincristine—sarcoma	0.00072	0.00332	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—sarcoma	0.000717	0.00331	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—sarcoma	0.000717	0.00331	CcSEcCtD
Fesoterodine—Urticaria—Etoposide—sarcoma	0.0007	0.00323	CcSEcCtD
Fesoterodine—Abdominal pain—Etoposide—sarcoma	0.000697	0.00321	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—sarcoma	0.000697	0.00321	CcSEcCtD
Fesoterodine—Urinary tract disorder—Epirubicin—sarcoma	0.000687	0.00317	CcSEcCtD
Fesoterodine—Rash—Vincristine—sarcoma	0.000686	0.00317	CcSEcCtD
Fesoterodine—Dermatitis—Vincristine—sarcoma	0.000686	0.00316	CcSEcCtD
Fesoterodine—Oedema peripheral—Epirubicin—sarcoma	0.000685	0.00316	CcSEcCtD
Fesoterodine—Urethral disorder—Epirubicin—sarcoma	0.000682	0.00315	CcSEcCtD
Fesoterodine—Headache—Vincristine—sarcoma	0.000682	0.00314	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000678	0.00313	CcSEcCtD
Fesoterodine—Rash—Mitoxantrone—sarcoma	0.000668	0.00308	CcSEcCtD
Fesoterodine—Dermatitis—Mitoxantrone—sarcoma	0.000668	0.00308	CcSEcCtD
Fesoterodine—Headache—Mitoxantrone—sarcoma	0.000664	0.00306	CcSEcCtD
Fesoterodine—Eye disorder—Epirubicin—sarcoma	0.00065	0.003	CcSEcCtD
Fesoterodine—Hypersensitivity—Etoposide—sarcoma	0.00065	0.003	CcSEcCtD
Fesoterodine—Nausea—Vincristine—sarcoma	0.000647	0.00298	CcSEcCtD
Fesoterodine—Cardiac disorder—Epirubicin—sarcoma	0.000646	0.00298	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—sarcoma	0.000636	0.00293	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—sarcoma	0.000634	0.00292	CcSEcCtD
Fesoterodine—Asthenia—Etoposide—sarcoma	0.000633	0.00292	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—sarcoma	0.000631	0.00291	CcSEcCtD
Fesoterodine—Nausea—Mitoxantrone—sarcoma	0.00063	0.0029	CcSEcCtD
Fesoterodine—Mediastinal disorder—Epirubicin—sarcoma	0.000627	0.00289	CcSEcCtD
Fesoterodine—Pruritus—Etoposide—sarcoma	0.000624	0.00288	CcSEcCtD
Fesoterodine—Mental disorder—Epirubicin—sarcoma	0.00061	0.00281	CcSEcCtD
Fesoterodine—Diarrhoea—Etoposide—sarcoma	0.000603	0.00278	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—sarcoma	0.000602	0.00277	CcSEcCtD
Fesoterodine—Cardiac disorder—Doxorubicin—sarcoma	0.000597	0.00276	CcSEcCtD
Fesoterodine—Flatulence—Epirubicin—sarcoma	0.000597	0.00275	CcSEcCtD
Fesoterodine—Dysgeusia—Epirubicin—sarcoma	0.000593	0.00274	CcSEcCtD
Fesoterodine—Back pain—Epirubicin—sarcoma	0.000586	0.0027	CcSEcCtD
Fesoterodine—Dizziness—Etoposide—sarcoma	0.000583	0.00269	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—sarcoma	0.00058	0.00268	CcSEcCtD
Fesoterodine—Vision blurred—Epirubicin—sarcoma	0.000571	0.00263	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—sarcoma	0.000564	0.0026	CcSEcCtD
Fesoterodine—Rash—Etoposide—sarcoma	0.000556	0.00256	CcSEcCtD
Fesoterodine—Dermatitis—Etoposide—sarcoma	0.000555	0.00256	CcSEcCtD
Fesoterodine—Headache—Etoposide—sarcoma	0.000552	0.00255	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—sarcoma	0.000552	0.00255	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—sarcoma	0.000549	0.00253	CcSEcCtD
Fesoterodine—Vertigo—Epirubicin—sarcoma	0.000544	0.00251	CcSEcCtD
Fesoterodine—Back pain—Doxorubicin—sarcoma	0.000542	0.0025	CcSEcCtD
Fesoterodine—Palpitations—Epirubicin—sarcoma	0.000535	0.00247	CcSEcCtD
Fesoterodine—Cough—Epirubicin—sarcoma	0.000528	0.00244	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—sarcoma	0.000528	0.00244	CcSEcCtD
Fesoterodine—Nausea—Etoposide—sarcoma	0.000524	0.00242	CcSEcCtD
Fesoterodine—Chest pain—Epirubicin—sarcoma	0.000516	0.00238	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000512	0.00236	CcSEcCtD
Fesoterodine—Dry mouth—Epirubicin—sarcoma	0.000504	0.00233	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—sarcoma	0.000503	0.00232	CcSEcCtD
Fesoterodine—Confusional state—Epirubicin—sarcoma	0.000498	0.0023	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—sarcoma	0.000495	0.00228	CcSEcCtD
Fesoterodine—Infection—Epirubicin—sarcoma	0.000491	0.00226	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—sarcoma	0.000489	0.00226	CcSEcCtD
Fesoterodine—Nervous system disorder—Epirubicin—sarcoma	0.000485	0.00224	CcSEcCtD
Fesoterodine—Tachycardia—Epirubicin—sarcoma	0.000482	0.00222	CcSEcCtD
Fesoterodine—Skin disorder—Epirubicin—sarcoma	0.00048	0.00221	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—sarcoma	0.000477	0.0022	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000474	0.00219	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—sarcoma	0.000467	0.00215	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—sarcoma	0.000461	0.00213	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—sarcoma	0.000454	0.0021	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—sarcoma	0.000449	0.00207	CcSEcCtD
Fesoterodine—Insomnia—Epirubicin—sarcoma	0.000447	0.00206	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—sarcoma	0.000446	0.00206	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—sarcoma	0.000444	0.00205	CcSEcCtD
Fesoterodine—Somnolence—Epirubicin—sarcoma	0.000439	0.00203	CcSEcCtD
Fesoterodine—Dyspepsia—Epirubicin—sarcoma	0.000435	0.00201	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000427	0.00197	CcSEcCtD
Fesoterodine—Fatigue—Epirubicin—sarcoma	0.000426	0.00197	CcSEcCtD
Fesoterodine—Constipation—Epirubicin—sarcoma	0.000423	0.00195	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—sarcoma	0.000414	0.00191	CcSEcCtD
Fesoterodine—Feeling abnormal—Epirubicin—sarcoma	0.000407	0.00188	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—sarcoma	0.000407	0.00188	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Epirubicin—sarcoma	0.000404	0.00186	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—sarcoma	0.000403	0.00186	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000395	0.00182	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—sarcoma	0.000394	0.00182	CcSEcCtD
Fesoterodine—Urticaria—Epirubicin—sarcoma	0.000393	0.00181	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—sarcoma	0.000391	0.0018	CcSEcCtD
Fesoterodine—Abdominal pain—Epirubicin—sarcoma	0.000391	0.0018	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—sarcoma	0.000377	0.00174	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000374	0.00172	CcSEcCtD
Fesoterodine—Hypersensitivity—Epirubicin—sarcoma	0.000364	0.00168	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—sarcoma	0.000363	0.00168	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—sarcoma	0.000362	0.00167	CcSEcCtD
Fesoterodine—Asthenia—Epirubicin—sarcoma	0.000355	0.00164	CcSEcCtD
Fesoterodine—Pruritus—Epirubicin—sarcoma	0.00035	0.00161	CcSEcCtD
Fesoterodine—Diarrhoea—Epirubicin—sarcoma	0.000338	0.00156	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—sarcoma	0.000337	0.00155	CcSEcCtD
Fesoterodine—Asthenia—Doxorubicin—sarcoma	0.000328	0.00151	CcSEcCtD
Fesoterodine—Dizziness—Epirubicin—sarcoma	0.000327	0.00151	CcSEcCtD
Fesoterodine—Pruritus—Doxorubicin—sarcoma	0.000324	0.00149	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—sarcoma	0.000313	0.00144	CcSEcCtD
Fesoterodine—Rash—Epirubicin—sarcoma	0.000312	0.00144	CcSEcCtD
Fesoterodine—Dermatitis—Epirubicin—sarcoma	0.000311	0.00144	CcSEcCtD
Fesoterodine—Headache—Epirubicin—sarcoma	0.00031	0.00143	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—sarcoma	0.000302	0.00139	CcSEcCtD
Fesoterodine—Nausea—Epirubicin—sarcoma	0.000294	0.00135	CcSEcCtD
Fesoterodine—Rash—Doxorubicin—sarcoma	0.000288	0.00133	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—sarcoma	0.000288	0.00133	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—sarcoma	0.000287	0.00132	CcSEcCtD
Fesoterodine—Nausea—Doxorubicin—sarcoma	0.000272	0.00125	CcSEcCtD
